ArticleAnnals of clinical and translational neurology2026
Changes in Immune-Inflammation Status and Prognosis in Pregnancy-Related Cerebral Venous Thrombosis.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveDistinguishing pathological changes from physiological adaptations in pregnancy-related cerebral venous thrombosis (CVT) is clinically challenging. This study aimed to characterize coagulation, immune-inflammation, and dehydration status in these patients and assess their prognostic value.
methodsIn this retrospective study, 120 participants were categorized into four groups: CVT with pregnancy-puerperium, CVT without pregnancy-puerperium, pregnancy-puerperium without CVT, and healthy nonpregnant female controls (30 per group). Laboratory indices were compared across groups. Neurological severity and functional outcomes were assessed using the National Institutes of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS) at admission, 7 days, and 3 months.
resultsCompared with CVT without pregnancy-puerperium, CVT with pregnancy-puerperium presented earlier after symptom onset and exhibited more severe neurological manifestations. CVT with pregnancy-puerperium showed higher fibrinogen and D-dimer levels than CVT without pregnancy-puerperium and healthy nonpregnant controls, but these markers overlapped with healthy pregnancy-puerperium controls. Several inflammatory markers were elevated compared with non-pregnancy groups, while neutrophil count, NLR, SII, and CRP overlapped with healthy pregnancy-puerperium controls. Elevated urine specific gravity was more frequent in CVT with pregnancy-puerperium than in healthy pregnancy-puerperium controls. Within this group, D-dimer and inflammatory markers correlated positively with NIHSS and mRS scores at admission and 7 days. Plasma osmolality > 310 mOsm/(kg·H
interpretationCVT during pregnancy-puerperium occurs against pregnancy-related hypercoagulability, immune-inflammatory activation, and fluid-balance changes, with overlap between pathological CVT-related changes and physiological pregnancy adaptations. D-dimer, inflammatory indices, and dehydration-related parameters may provide prognostic information for risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.